%0 Journal Article
%A Doege, Daniela
%A Frick, Julien
%A Eckford, Rachel
%A Koch-Gallenkamp, Lena
%A Schlander, Michael
%A Arndt, Volker
%T Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID-19 pandemic.
%J International journal of cancer
%V 156
%N 4
%@ 0020-7136
%C Bognor Regis
%I Wiley-Liss
%M DKFZ-2024-01992
%P 711-722
%D 2025
%Z #EA:C070#EA:C071#EA:M110#LA:C070#LA:C071#LA:M110# / 2025 Feb 15;156(4):711-722
%X Treatment modifications and contact restrictions were common during the COVID-19 pandemic and can be stressors for mental health. There is a lack of studies assessing pandemic-related risk factors for anxiety and depression of cancer patients and survivors systematically in multifactorial models. A total of 2391 participants, mean age 65.5 years, ≤5 years post-diagnosis of either lung, prostate, breast, colorectal cancer, or leukemia/lymphoma, were recruited in 2021 via the Baden-Württemberg Cancer Registry, Germany. Sociodemographic information, pandemic-related treatment modifications, contact restrictions, and anxiety/depression (Hospital Anxiety and Depression Scale, HADS) were assessed via self-administered questionnaire. Clinical information (diagnosis, stage, and treatment information) was obtained from the cancer registry. Overall, 22
%K SARS‐CoV‐2 (Other)
%K cancer registry (Other)
%K mental health (Other)
%K social contact (Other)
%K treatment modifications (Other)
%K well‐being (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39361297
%R 10.1002/ijc.35204
%U https://inrepo02.dkfz.de/record/293862